Market Research Report
Topical Absorbable Hemostats (Wound Care Devices) - Global Market Analysis and Forecast Model
|Published by||GlobalData||Product code||758980|
Delivery time: 1-2 business days
|Topical Absorbable Hemostats (Wound Care Devices) - Global Market Analysis and Forecast Model|
|Published: October 31, 2018||Content info:||
Topical Absorbable Hemostats (Wound Care Devices) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Wound Care Devices therapeutic area.
Topical Absorbable Hemostats (TAH) are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature and other conventional methods is ineffective. They are inserted to remove excess blood, thereby preventing further bleeding and clearing up the operating site for the surgeon. Topical Absorbable Hemostats (TAH) products are often plant or gelatin-based and act as mechanical barriers and/or help with vasoconstriction and are a platform for platelet aggregation in order to slow the flow of blood and give the patient's body time to form a clot. The Topical Absorbable Hemostats (TAH) market is segmented into combination hemostats - pads, oxidized regenerated cellulose based hemostats, polysaccharide based hemostats, gelatin based hemostats, and collagen based hemostats.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Baxter, C.R. Bard, Ethicon, Gelita, Pfizer, Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -